1Dosis - Wirkungs - Studie zum Einsatz von inhalativem Stickstoffmonoxid bei Patienten mit schwerem akutem LungenversagenMatthias Bösel 234171.1891.2101.3111.4122132.1142.2152.3162.42.5172.63183.119203.221531#34022530#307532#2972324585#415605#3843.325564#218563#20126576#220552#21127563#232564#21728576#237576#21729586#291587#2923.430563#232563#23531576#22932576#253563#22333540#237564#24134576#26235605#338605#3454364.13738394.2404.34.44154243 Literaturverzeichnis444546474849 Danksagung50 Lebenslauf51 Erklärung an Eides Statt52deInhaltsverzeichnisHilfe Literaturverzeichnis 1 Ashbaugh DG, Bigelow DB, Petty TL, Levine BE: Acute respiratory distress in adults. Lancet. 1967; 2: S.319-323 2 Zapol WM, Snider MT: Pulmonary hypertension in severe acute respiratory failure. N Engl J Med. 1977; 296: S.476-480 3 Sibbald WJ, Driedger AA, Myers ML, Short AI, Wells GA: Biventricular function in the adult respiratory distress syndrome. Chest. 1983; 84: S.126-134 4 Marshall BE, Hanson CW, Frasch F, Marshall C: Role of hypoxic pulmonary vasoconstriction in pulmonary gas exchange and blood flow distribution. 2. Pathophysiology. Intensive Care Med. 1994; 20: S.379-389 5 Vlahakes GJ, Turley K, Hoffman JI: The pathophysiology of failure in acute right ventricular hypertension: hemodynamic and biochemical correlations. Circulation. 1981; 63: S.87-95 6 Villar J, Blazquez MA, Lubillo S, Quintana J, Manzano JL: Pulmonary hypertension in acute respiratory failure. Crit Care Med. 1989; 17: S.523-526 7 Fowler AA, Hamman RF, Good JT, et al.: Adult respiratory distress syndrome: risk with common predispositions. Ann Intern Med. 1983; 98: S.593-597 8 Hudson LD, Milberg JA, Anardi D, Maunder RJ: Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med. 1995; 151: S.293-301 9 National Heart and Lung Institute: Task Force on Problems, Resarch Approaches, Needs: The Lung Program.. Band Publication No. (NHI) 73-432.

Washington DC

, Department of Health, Education and Welfare 1972, S.165-180 10 Villar J, Slutsky AS: The incidence of the adult respiratory distress syndrome. Am Rev Respir Dis. 1989; 140: S.814-816 11 Thomsen GE, Morris AH: Incidence of the adult respiratory distress syndrome in the state of Utah. Am J Respir Crit Care Med. 1995; 152: S.965-971 12 Lewandowski K, Metz J, Deutschmann C, et al.: Incidence, severity, and mortality of acute respiratory failure in Berlin, Germany. Am J Respir Crit Care Med. 1995; 151: S.1121-1125 13 Sloane PJ, Gee MH, Gottlieb JE, et al.: A multicenter registry of patients with acute respiratory distress syndrome. Physiology and outcome. Am Rev Respir Dis. 1992; 146: S.419-426 14 Milberg JA, Davis DR, Steinberg KP, Hudson LD: Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993. Jama. 1995; 273: S.306-309 15 Zapol WM, Snider MT, Hill JD, et al.: Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. Jama. 1979; 242: S.2193-2196 16 NHLBI Divison of Lung Diseases: Extracorporeal support for respiratory insufficiency. A colloborative sytudy in response to RFP.. Band 73-20. NHLI, 1979 17 Zobel G, Rodl S, Urlesberger B, Dacar D, Trafojer U, Trantina A: The effect of positive end-expiratory pressure during partial liquid ventilation in acute lung injury in piglets. Crit Care Med. 1999; 27: S.1934-1939 18 Colton DM, Till GO, Johnson KJ, Dean SB, Bartlett RH, Hirschl RB: Neutrophil accumulation is reduced during partial liquid ventilation. Crit Care Med. 1998; 26: S.1716-1724 19 Rotta AT, Gunnarsson B, Hernan LJ, Fuhrman BP, Steinhorn DM: Partial liquid ventilation influences pulmonary histopathology in an animal model of acute lung injury. J Crit Care. 1999; 14: S.84-92 20 Steinhorn DM, Leach CL, Fuhrman BP, Holm BA: Partial liquid ventilation enhances surfactant phospholipid production. Crit Care Med. 1996; 24: S.1252-1256 21 Radermacher P, Huet Y, Pluskwa F, et al.: Comparison of ketanserin and sodium nitroprusside in patients with severe ARDS. Anesthesiology. 1988; 68: S.152-157 22 Wagner PD, Saltzman HA, West JB: Measurement of continuous distributions of ventilation-perfusion ratios: theory. J Appl Physiol. 1974; 36: S.588-599 23 Radermacher P, Santak B, Becker H, Falke KJª: Prostaglandin E1 and nitroglycerin reduce pulmonary capillary pressure but worsen ventilation-perfusion distributions in patients with adult respiratory distress syndrome. Anesthesiology. 1989; 70: S.601-606 24 Ichinose F, Adrie C, Hurford WE, Bloch KD, Zapol WM: Selective pulmonary vasodilation induced by aerosolized zaprinast. Anesthesiology. 1998; 88: S.410-416 25 Mitchell HH, Shonnle H, Grindley H: The origin of nitrate in the urine. J Biol Chem. 1916; 24: S.461 26 Norman V, Keith CH: Nitrogen oxides in tabacco smoke. Nature. 1965; 205: S.915-916 27 Higenbottam T, Borland C: NO yields of contemporary UK, US and French cigarettes. Int J Epedemiol. 1987; 16: S.31-34 28 Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980; 288: S.Nature 29 Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G: Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A. 1987; 84: S.9265-9269 30 Palmer RM, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987; 327: S.524-526 31 Moncada S, Palmer RM, Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991; 43: S.109-142 32 Brenner BM, Troy JL, Ballermann BJ: Endothelium-dependent vascular responses. Mediators and mechanisms. J Clin Invest. 1989; 84: S.1373-1378 33 Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM: Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation. 1991; 83: S.2038-2047 34 Ignarro LJ, Lippton H, Edwards JC, et al.: Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther. 1981; 218: S.739-749 35 Forstermann U, Closs EI, Pollock JS, et al.: Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension. 1994; 23: S.1121-1131 36 Radomski MW, Palmer RM, Moncada S: The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol. 1987; 92: S.639-646 37 Hibbs JB, Jr., Taintor RR, Vavrin Z, Rachlin EM: Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun. 1988; 157: S.87-94 38 Dupuy PM, Shore SA, Drazen JM, Frostell C, Hill WA, Zapol WM: Bronchodilator action of inhaled nitric oxide in guinea pigs. J Clin Invest. 1992; 90: S.421-428 39 Pison U, Lopez FA, Heidelmeyer CF, Rossaint R, Falke KJ: Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction without impairing gas exchange. J Appl Physiol. 1993; 74: S.1287-1292 40 Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM: Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med. 1993; 328: S.399-405 41 Iotti GA, Olivei MC, Palo A, Galbusera C, Veronesi R, Braschi A: Acute effects of inhaled nitric oxide in adult respiratory distress syndrome. Eur Respir J. 1998; 12: S.1164-1171 42 Troncy E, Collet JP, Shapiro S, et al.: Inhaled nitric oxide in acute respiratory distress syndrome: a pilot randomized controlled study. Am J Respir Crit Care Med. 1998; 157: S.1483-1488 43 Olivei MC, Palo A, Galbusera C, et al.: Inhaled nitrous oxide (NO) for the treatment of ARDS Minerva Anestesiol. 1997; 63: S.61-68 44 Borelli M, Lampati L, Vascotto E, Fumagalli R, Pesenti A: Hemodynamic and gas exchange response to inhaled nitric oxide and prone positioning in acute respiratory distress syndrome patients. Crit Care Med. 2000; 28: S.2707-2712 45 Adrie C, Holzmann A, Hirani WM, Zapol WM, Hurford WE: Effects of intravenous Zaprinast and inhaled nitric oxide on pulmonary hemodynamics and gas exchange in an bovine model of acute respiratory distress syndrome. Anesthesiology. 2000; 93: S.422-430 46 Murray JF, Matthay MA, Luce JM, Flick MR: An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis. 1988; 138: S.720-723 47 Levy B, Bollaert PE, Bauer P, Nace L, Audibert G, Larcan A: Therapeutic optimization including inhaled nitric oxide in adult respiratory distress syndrom in a polyvalent intensive care unit. J Trauma. 1995; 38: S.370-374 48 Gerlach H, Rossaint R, Pappert D, Falke KJ: Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest. 1993; 23: S.499-502 49 Lowson SM, Rich GF, McArdle PA, Jaidev J, Morris GN: The response to varying concentrations of inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesth Analg. 1996; 82: S.574-581 50 Demirakca S, Dotsch J, Knothe C, et al.: Inhaled nitric oxide in neonatal and pediatric acute respiratory distress syndrome: dose response, prolonged inhalation, and weaning. Crit Care Med. 1996; 24: S.1913-1919 51 Rossaint R, Gerlach H, Schmidt-Ruhnke H, et al.: Efficacy of inhaled nitric oxide in patients with severe ARDS. Chest. 1995; 107: S.1107-1115 52 Michael JR, Barton RG, Saffle JR, et al.: Inhaled nitric oxide versus conventional therapy: effect on oxygenation in ARDS. Am J Respir Crit Care Med. 1998; 157: S.1372-1380 53 Roberts JD et al.: Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The inhaled nitric oxide study group. N Engl J Med. 1997; 328: S.399-405 54 Cannon RO, Schechter AN, Panza JA, Ognibene FP, Peas-Fye ME, Waclawik MA, Shelhamer JH, Gladwin MT: Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery. J Clin Invest. 2002; 108: S.279-287 55 Rassaf T, Preik M, Kleinbongard P, Lauer T, Heiß C, Strauer BE, Feelisch M, Kelm M: Evidence for in vivo transport of biactive nirtic oxide in human plasma. J Clin Invest. 2002; 109: S.1241-1248 56 Lundin S, Mang H, Smithies M, Stenqvist O, Frostell C: Inhalation of nitric oxide in acute lung injury: results of a European multicentre study. The European Study Group of Inhaled Nitric Oxide. Intensive Care Med. 1999; 25: S.911-919 57 Rossaint R, Slama K, Steudel W, et al.: Effects of inhaled nitric oxide on right ventricular function in severe acute respiratory distress syndrome. Intensive Care Med. 1995; 21: S.197-203 58 Frostell CG, Blomqvist H, Hedenstierna G, Lundberg J, Zapol WM: Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology. 1993; 78: S.427-435 59 McIntyre RD, Moore Fa, PiedalueF, Haenel JS, Fullerton DA: Inhaled nitric oxide variably improves oxygenation and pulmonary hypertension in patients with acute respiratory distress syndrom. J Trauma. 1995; 39: S.418-425 60 Fierobe L, Brunet F, Dhainaut JF, et al.: Effect of inhaled nitric oxide on right ventricular function in adult respiratory distress syndrome. Am J Respir Crit Care Med. 1995; 151: S.1414-1419 61 Dellinger RP, Zimmerman JL, Taylor RW, et al.: Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med. 1998; 26: S.15-23 62 Gerlach H, Rossaint R, Pappert D, Knorr M, Falke KJ: Autoinhalation of nitric oxide after endogenous synthesis in nasopharynx. Lancet. 1994; 343: S.518-519 63 Lundberg JO, Settergren G, Gelinder S, Lundberg JM, Alving K, Weitzberg E: Inhalation of nasally derived nitric oxide modulates pulmonary function in humans. Acta physiologica Scandinavica. 1996; 158: S.343-347